Search

Patients with profound immunosuppression after undergoing hematopoietic stem-cell transplantation or receiving chimeric antigen receptor (CAR) T cell therapy may shed viable SARS-CoV-2 for at least two months.

… Monday, December 14, 2020 Patients with profound immunosuppression after undergoing hematopoietic stem-cell transplantation or receiving chimeric antigen receptor (CAR) T cell therapy may shed viable SARS-CoV-2 for at least two months, according to a retrospective study of 18 cancer patients treated

Learn how exercise can help many people live longer after they are diagnosed with cancer, according to a new study from MSK's Exercise-Oncology Service.

… Friday, September 15, 2023   For decades, it’s been known that consistent exercise can help people live healthier lives, in part by lowering the risk of cancer. But can exercise help a person after cancer is diagnosed — potentially improving the amount of time someone might live after a diagnosis? That

During the plenary session at the American Association for Cancer Research’s (AACR) virtual annual meeting I on Tuesday, April 28, Memorial Sloan Kettering (MSK) expert Louis P. Voigt, MD, Intensivist, spoke about disparities with cancer and COVID-19 patients.

… Tuesday, April 28, 2020 During the plenary session at the American Association for Cancer Research’s (AACR) virtual annual meeting I on Tuesday, April 28, Memorial Sloan Kettering (MSK) expert Louis P. Voigt, MD , Intensivist, spoke about disparities with cancer and COVID-19 patients. Three key takeaways

Whole breast radiation (WBRT) significantly reduced local recurrence in women with “good risk” (low risk) ductal carcinoma in situ (DCIS) following breast conservation surgery, according to researchers from Memorial Sloan Kettering Cancer Center, who presented this data in a press conference at the annual meeting of the American Society for Radiation Oncology (ASTRO).

… Sunday, October 21, 2018 San Antonio, October 21, 2018 — Whole breast radiation (WBRT) significantly reduced local recurrence in women with “good risk” (low risk) ductal carcinoma in situ (DCIS) following breast conservation surgery, according to researchers from Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSKCC) today announced a major commitment from publisher, real estate developer, and MSKCC Board member Mortimer B. Zuckerman of $100 million from his charitable trust toward Memorial Sloan Kettering's new cancer research facility, including a 23-story laboratory structure that opens this month. Mr. Zuckerman's donation is the largest single commitment by an individual in Memorial Sloan Kettering's history.

… Wednesday, May 10, 2006 Memorial Sloan Kettering Cancer Center (MSKCC) today announced a major commitment from publisher, real estate developer, and MSKCC Board member Mortimer B. Zuckerman of $100 million from his charitable trust toward Memorial Sloan Kettering’s new cancer research facility, including

A study from Memorial Sloan Kettering found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations.

… Monday, June 22, 2020 A study from Memorial Sloan Kettering (MSK) found that young patients ages 18 to 39 with early-onset cancer have an especially high risk of harboring inherited genetic (germline) mutations. Results from this study were presented by Zsofia K. Stadler, MD , medical oncologist at MSK

A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs) can reestablish the health-promoting bacteria that are often damaged by intense antibiotic treatment in people who have stem cell or bone marrow transplants for blood cancer.

… Friday, September 28, 2018 Bottom Line: A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs) can reestablish the health-promoting bacteria that are often damaged by intense antibiotic treatment in people who have stem cell or bone

Take a short quiz to test your knowledge of breast cancer screening.

… Tuesday, October 3, 2017 Summary Does breast cancer screening hurt? How often should you get a mammogram? Get the answers to these questions and more by taking this quiz. It can be hard to stay on top of current breast cancer screening guidelines because the advice is sometimes confusing or conflicting

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 20 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.

… Thursday, November 18, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 20 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute

Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.

… Friday, January 13, 2012 Summary Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy. Researchers at Memorial Sloan Kettering have shown the usefulness of a scale